Teva Pharmaceutical Industries Limited (TEV) — Financial Flexibility Index
Teva Pharmaceutical Industries Limited (TEV) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of €128.00 Million (operating CF €-40.00 Million minus capex €168.00 Million) represents 0% of total liabilities (€31.81 Billion). Check Teva Pharmaceutical Industries Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Teva Pharmaceutical Industries Limited Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Teva Pharmaceutical Industries Limited across 11 annual periods. For the full cash flow conversion analysis, see Teva Pharmaceutical Industries Limited (TEV) cash flow conversion.
Annual Financial Flexibility Index for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year free cash flow to debt coverage for Teva Pharmaceutical Industries Limited. Explore cash flow to debt ratio of Teva Pharmaceutical Industries Limited to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | €2.15 Billion | €1.65 Billion | €32.83 Billion | ▲ +26.1% |
| 2024 | 0.05x | €1.75 Billion | €1.25 Billion | €33.61 Billion | ▲ +7.6% |
| 2023 | 0.05x | €1.71 Billion | €1.16 Billion | €35.35 Billion | ▼ -20.3% |
| 2022 | 0.06x | €2.14 Billion | €1.59 Billion | €35.31 Billion | ▲ +62.1% |
| 2021 | 0.04x | €1.36 Billion | €798.00 Million | €36.42 Billion | ▼ -17.6% |
| 2020 | 0.05x | €1.79 Billion | €1.22 Billion | €39.58 Billion | ▲ +51.0% |
| 2019 | 0.03x | €1.27 Billion | €748.00 Million | €42.41 Billion | ▼ -56.5% |
| 2018 | 0.07x | €3.10 Billion | €2.45 Billion | €44.89 Billion | ▲ +15.5% |
| 2017 | 0.06x | €3.10 Billion | €2.23 Billion | €51.87 Billion | ▼ -27.8% |
| 2016 | 0.08x | €4.79 Billion | €3.89 Billion | €57.90 Billion | ▼ -68.1% |
| 2015 | 0.26x | €6.31 Billion | €5.54 Billion | €24.31 Billion | — |